# US 2023/0069429 A1 · Size-exclusive dose-controllable drug delivery implant

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0069429 A1
- Document ID: US20230069429A1
- Status: Published application
- Kind: A1
- Application number: 17/985,828
- Filed: 2022-11-12
- Published: 2023-03-02
- Earliest claimed: 2018-05-01
- Inventors: Yoonjee Park; Xingyu He; S. Kevin Li
- Web page: https://patentgrep.com/patent/US20230069429A1

## CPC

- A61K 41/0028: {Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds}
- A61F 9/0017: {implantable in, or in contact with, the eye, e.g. ocular inserts}
- A61K 9/0092: {Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes}
- A61K 9/06: Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)}
- A61K 9/127: Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K 9/51: Nanocapsules; {Nanoparticles; (nanotubes A61K9/0092; polymeric micelles A61K9/1075; polymersomes A61K9/1273; pure drug nanoparticles A61K9/14; drug nanoparticles with adsorbed surface modifiers A61K9/141; conjugates, e.g. between drug and non-active nanoparticles, A61K47/50; preparations for in vivo diagnosis A61K49/00; with radioactive substances A61K51/00)}
- A61K 9/5153: {Polyesters, e.g. poly(lactide-co-glycolide)}
- A61N 5/062: {Photodynamic therapy, i.e. excitation of an agent}
- B29D 23/00: Producing tubular articles (B29D24/00 takes precedence)
- A61K 47/34: Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers (A61K47/10 takes precedence)
- A61N 5/067: using laser light
- A61N 2005/0659: {infrared}
- B29K 2105/0061: {Gel or sol}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- B29D: PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE (making granules B29B9/00; making preforms B29B11/00)
- B29K: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR {MOULDS, } REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS

## Abstract

An implant device includes a polymer tube including an enclosed inner space, and a mixture of a hydrogel and a plurality of nanoparticles within the enclosed inner space. Each of the plurality of nanoparticles includes a shell, payload within the shell, and one or more photothermal agents on a surface of the shell. A wall of the polymer tube includes one or more layers of nanoporous polymer sheets including a plurality of pores. The dimension of the nanoparticles is greater than the dimension of the pores, and the dimension of the payload is smaller than the dimension of the pores.

## Claims

### Claim 1

A method for releasing payload in an implant device, the method comprising:
placing the implant device in a syringe needle;
injecting the implant device into an object; and
irradiating a laser at the implant device,
wherein the implant device comprise:
a polymer tube including an inner space; and
a plurality of particles within the inner space, wherein each of the plurality of particles includes:
a lipid shell;
drug within the shell; and
one or more photothermal agents.

### Claim 2 (depends on 1)

The method of claim 1, wherein:
a wall of the polymer capsule includes one or more layers of porous polymer sheets;
the porous polymer sheet includes a plurality of pores;
a dimension of the particles in any direction is greater than a dimension of the pores; and
a dimension of the payload is smaller than a dimension of the pores.

### Claim 3 (depends on 1)

The method of claim 1, wherein:
each of the plurality of particles is configured to output the drug outside the lipid shell in response to the irradiated laser such that the drug go through the plurality of pores.

### Claim 4 (depends on 1)

The method of claim 1, wherein the laser has a wavelength between 700 nanometers and 1,000 nanometers.

### Claim 5 (depends on 1)

The method of claim 1, wherein the phototermal agent is a gold nanorod.

### Claim 6 (depends on 1)

The method of claim 1, wherein the polymer capsule is biodegradable.

### Claim 7 (depends on 1)

The method of claim 1, wherein the polymer capsule includes at least one of poly lactic-glycolic acid, or poly caprolacton.
